FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

OND 55 Drug Approvals in 2023

The CDER Office of New Drugs says it participated in 55 novel drug approvals in 2023.

latest-news-card-1
Biologics

Pfizer Gets Traditional Approval for Tivdak

FDA gives Pfizer traditional approval for its previously accelerated-approved Tivdak (tisotumab vedotin-tftv) for recurrent or metastatic cervical can...

latest-news-card-1
Federal Register

Info Collection on FDA Recall Regs

Federal Register notice: FDA sends to OMB an information collection extension entitled FDA Recall Regulations 21 CFR Part 7.

latest-news-card-1
Federal Register

Listening Session on Advisory Committee Revamp

Federal Register notice: FDA announces a 6/13 virtual public meeting entitled Listening Session: Optimizing FDAs Use of and Processes for Advisory Com...

latest-news-card-1
Medical Devices

QS Violations in Unapproved Spectrum Devices

FDA warns the UKs Spectrum Medical about QS violations in its production of unapproved perfusion system devices.

latest-news-card-1
Medical Devices

VITEK 2 Antimicrobial Test Cards Recalled

BioMrieux recalls its VITEK 2 AST antimicrobial sensitivity testing cards due to a higher concentration of ceftriaxone antibiotic in two wells.

latest-news-card-1
Federal Register

Draft Guide on Cell/Gene Therapy Considerations

Federal Register notice: FDA makes available a draft document entitled Considerations for the Use of Human- and Animal-Derived Materials and Component...

latest-news-card-1
Medical Devices

SonarMed Recalls Airway Sensors

SonarMed recalls its SonarMed Airway acoustic ventilator sensors due to a restricted inner diameter of the device resulting in difficulty passing a su...

latest-news-card-1
Federal Register

Panel to Review Novo Nordisks Insulin Icodec

Federal Register notice: FDA schedules a 5/24 Advisory Committee meeting to discuss Novo Nordisks BLA for insulin icodec.

latest-news-card-1
Biologics

Human Allogeneic Cell Safety Testing Guide

FDA posts a draft guidance entitled Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products.